Concepedia

Uwe Klein

UK

Statistics

Publications

13

Citations

1.1K

H-Index

12

Active since

1994

Affiliations

Theravance Biopharma (United States)(Current)

Max Planck Institute of Biophysics

Max Planck Society

University of California, San Francisco

Uwe Klein is an author at Theravance Biopharma (United States) specializing in pharmacology, medicinal chemistry, and molecular pharmacology.

Publications per year

1994–2018

13

Publications

13

Alteration of the Myometrial Plasma Membrane Cholesterol Content with .beta.-Cyclodextrin Modulates the Binding Affinity of the Oxytocin Receptor

Uwe Klein, Gerald Gimpl, Falk Fahrenholz · Biochemistry · 1995 · 542 citations

, , +15

Expression of the Human Oxytocin Receptor in Baculovirus-Infected Insect Cells: High-Affinity Binding Is Induced by a Cholesterol-Cyclodextrin Complex

Gerald Gimpl, Uwe Klein, Helmut Reilaender et al. · Biochemistry · 1995 · 163 citations

, , +10

A Novel Interaction between Adrenergic Receptors and the α-Subunit of Eukaryotic Initiation Factor 2B

Uwe Klein, M. Teresa Ramirez, Brian K. Kobilka et al. · Journal of Biological Chemistry · 1997 · 75 citations · Full text

, , +15

Concomitant Angiotensin AT1 Receptor Antagonism and Neprilysin Inhibition Produces Omapatrilat-like Antihypertensive Effects Without Promoting Tracheal Plasma Extravasation in the Rat

Laxminarayan G. Hegde, Cecile Yu, Travis Renner et al. · Journal of Cardiovascular Pharmacology · 2011 · 64 citations

, , +14

THRX-198321 Is a Bifunctional Muscarinic Receptor Antagonist and β2-Adrenoceptor Agonist (MABA) That Binds in a Bimodal and Multivalent Manner

Tod Steinfeld, Adam D. Hughes, Uwe Klein et al. · Molecular Pharmacology · 2010 · 42 citations

, , +15

1–5 of 13